In which conditions does a peripheral blood smear show giant platelets?

Giant Platelets on Peripheral Smear: Key Conditions

Giant platelets on peripheral blood smear are most commonly seen in inherited platelet function disorders, particularly Bernard-Soulier syndrome (BSS), MYH9-related disorders, and Grey Platelet Syndrome (GPS), as well as in velo-cardio-facial syndrome and certain other hereditary macrothrombocytopenias 1.

Primary Inherited Conditions

Bernard-Soulier Syndrome (BSS)

• Classic presentation with macrothrombocytopenia and giant platelets
• Platelets show disproportionately large size in both discoid and shape-changed forms 2
• Associated with defective GPIb/IX/V complex (CD42b, CD42a reduced on flow cytometry) 1
• Bleeding tendency due to impaired platelet adhesion

MYH9-Related Disorders

• Giant platelets with characteristic Döhle-like inclusion bodies in leukocytes
• Associated with defective adhesion and thrombus formation under shear conditions 1
• May present with additional features: hearing loss, cataracts, nephritis

Grey Platelet Syndrome (GPS)

• Large, agranular platelets that appear grey on Wright-Giemsa stain 3
• Caused by NBEAL2 gene mutations
• Associated with splenomegaly and bone marrow fibrosis 3
• Electron microscopy confirms absent or markedly reduced α-granules

Other Hereditary Macrothrombocytopenias

• Velo-cardio-facial syndrome (del22q11.2): giant platelets with cardiac/facial anomalies 1
• Paris-Trousseau syndrome (del11q23): giant platelets with FLI1 deletion 1
• May-Hegglin anomaly: giant platelets with leukocyte inclusions 2
• Montreal Platelet Syndrome (MPS): disproportionately large platelets during shape change 2
• GATA1 deficiency: macrothrombocytopenia with dyserythropoiesis 1
• Filaminopathy (FLNA mutations): giant platelets with increased spreading 1

Acquired Conditions

Type 2B von Willebrand Disease

• Large/giant platelets with spontaneous platelet agglutinates 4
• Enhanced ristocetin-induced platelet aggregation
• Distinguish from platelet-type VWD through mixing studies 1

Alport Syndrome

• Rare association with thrombocytopenia and giant unusual platelets 5
• Primarily a renal disorder; platelet abnormalities may be overlooked

Critical Diagnostic Pitfalls

Pseudothrombocytopenia

Do not confuse true giant platelets with artifactual findings:

• EDTA-induced platelet clumping creates falsely low counts but platelets are normal-sized individually 4
• Large/giant platelets may be undercounted by automated analyzers because they exceed size thresholds and are misclassified as small red cells or debris 4
• Always examine the blood smear directly when automated counts show thrombocytopenia

Post-Splenectomy State

• Increased small-sized megakaryocytes in circulation (not giant platelets) 6
• Associated with reactive thrombocytosis, not macrothrombocytopenia

Diagnostic Algorithm

When giant platelets are identified:

1. Confirm on fresh blood smear - examine EDTA sample immediately to exclude artifact 4

2. Assess platelet count and bleeding history:

   • Thrombocytopenia + bleeding → inherited platelet disorder likely
   • Normal/high count → consider reactive causes or myeloproliferative disorder

3. First-line testing 1:

   • Flow cytometry for GPIb (CD42b), GPIb/IX (CD42a), GPIIb/IIIa (CD41/CD61)
   • Complete blood count with manual differential (check for leukocyte inclusions)
   • Light transmission aggregometry with ristocetin

4. Second-line testing based on initial results:

   • Electron microscopy to assess α-granule content (GPS) 3
   • Genetic testing for NBEAL2, MYH9, FLNA, GATA1, or chromosomal deletions 1
   • VWF studies if ristocetin hyperresponsive 1

The presence of giant platelets with thrombocytopenia and bleeding should prompt immediate hematology referral for inherited platelet function disorder evaluation, as these conditions carry lifelong bleeding risk and require specialized management 1.